We have a formidable track record when it comes to turning world class research into globally adopted commercial opportunities, with our innovations contributing billions of dollars to the Australian economy annually.

Our team of IP and commercialisation experts help navigate the multifaceted commercialisation process, to maximise the impact of research. We provide tailored advice regarding intellectual property management, licensing, spin-outs and other commercialisation options. Large, complex, licensing and equity transactions are our speciality. Our licensing revenue is re-invested into the innovation eco-system, magnifying our impact and research into deep tech science.

Our commercialisation record:

As at 2018:

  • 697 patent families
  • 497 active licenses
  • 170+ companies started from CSIRO technology
  • $121M total value of CSIRO interest in portfolio companies

In 2018:

  • $43M in IP revenue
  • $48M in revenue generated by portfolio companies
  • $76M in capital raised by portfolio companies

Our equity portfolio

Supporting the growth of high-tech companies

Over 170 companies have been born from CSIRO technology. We currently hold equity interests in over 30 companies, who have a combined market capitalisation in excess of AUD$1 billion.

We have developed a number of commercialisation pathways to convert our IP into real outcomes and impact for Australia including licensing and assigning IP, research for equity as well as spin-outs and joint ventures.

Snapshot of our equity portfolio companies

Contact us

Your contact details

First name must be filled in

We'll need to know what you want to contact us about so we can give you an answer.